Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KCSP Trial of CONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After NeoadjUvant Concurrent ChemoraDiothErapy: a Multicenter, Randomized Controlled Trial (KONCLUDE)

NCT02843191 is registered in ClinicalTrials.gov with Kyung Hee University Hospital at Gangdong as lead sponsor.

NCT NCT02843191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KCSP Trial of CONsolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After NeoadjUvant Concurrent ChemoraDiothErapy: a Multicenter, Randomized Controlled Trial (KONCLUDE)
Lead sponsor
Kyung Hee University Hospital at Gangdong
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 7, 2016
Completion date
June 30, 2026
Enrollment
358 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer